Naltrexone renders one-session exposure therapy less effective: A controlled pilot study

Andrea T. Kozak, C. Richard Spates, Dennis E. McChargue, Katherine C. Bailey, Kristin L. Schneider, Michael R. Liepman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In vivo exposure has become the gold standard treatment for specific phobia. The endogenous opioid system is one mechanism proposed to explain why exposure provides such quick and effective treatment for specific phobia. The effect of naltrexone on fear and avoidance behavior was investigated among 15 specific phobia participants who received exposure treatment. Participants were randomly assigned to receive naltrexone, placebo, or no drug prior to attending one-session exposure treatment. Mixed effects regression results revealed that across time, the naltrexone group tolerated significantly less time in the room with the feared animal (Behavioral Avoidance Index) as compared to the placebo and no drug groups. Phobic individuals assigned to the naltrexone group had significantly higher fear ratings across time in comparison to the placebo group. Results provide support for the endogenous opioid system as a potential underlying biological mechanism associated with behavioral changes during in vivo exposure.

Original languageEnglish (US)
Pages (from-to)142-152
Number of pages11
JournalJournal of Anxiety Disorders
Volume21
Issue number1
DOIs
StatePublished - Jan 22 2007

Fingerprint

Implosive Therapy
Naltrexone
Placebos
Opioid Analgesics
Fear
Avoidance Learning
Therapeutics
Pharmaceutical Preparations
Specific Phobia

Keywords

  • Behavioral assessment
  • Endogenous opiates
  • Naltrexone
  • Phobias

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Naltrexone renders one-session exposure therapy less effective : A controlled pilot study. / Kozak, Andrea T.; Spates, C. Richard; McChargue, Dennis E.; Bailey, Katherine C.; Schneider, Kristin L.; Liepman, Michael R.

In: Journal of Anxiety Disorders, Vol. 21, No. 1, 22.01.2007, p. 142-152.

Research output: Contribution to journalArticle

Kozak, Andrea T. ; Spates, C. Richard ; McChargue, Dennis E. ; Bailey, Katherine C. ; Schneider, Kristin L. ; Liepman, Michael R. / Naltrexone renders one-session exposure therapy less effective : A controlled pilot study. In: Journal of Anxiety Disorders. 2007 ; Vol. 21, No. 1. pp. 142-152.
@article{f249efddd8084c5590f79871632800f0,
title = "Naltrexone renders one-session exposure therapy less effective: A controlled pilot study",
abstract = "In vivo exposure has become the gold standard treatment for specific phobia. The endogenous opioid system is one mechanism proposed to explain why exposure provides such quick and effective treatment for specific phobia. The effect of naltrexone on fear and avoidance behavior was investigated among 15 specific phobia participants who received exposure treatment. Participants were randomly assigned to receive naltrexone, placebo, or no drug prior to attending one-session exposure treatment. Mixed effects regression results revealed that across time, the naltrexone group tolerated significantly less time in the room with the feared animal (Behavioral Avoidance Index) as compared to the placebo and no drug groups. Phobic individuals assigned to the naltrexone group had significantly higher fear ratings across time in comparison to the placebo group. Results provide support for the endogenous opioid system as a potential underlying biological mechanism associated with behavioral changes during in vivo exposure.",
keywords = "Behavioral assessment, Endogenous opiates, Naltrexone, Phobias",
author = "Kozak, {Andrea T.} and Spates, {C. Richard} and McChargue, {Dennis E.} and Bailey, {Katherine C.} and Schneider, {Kristin L.} and Liepman, {Michael R.}",
year = "2007",
month = "1",
day = "22",
doi = "10.1016/j.janxdis.2006.03.011",
language = "English (US)",
volume = "21",
pages = "142--152",
journal = "Journal of Anxiety Disorders",
issn = "0887-6185",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Naltrexone renders one-session exposure therapy less effective

T2 - A controlled pilot study

AU - Kozak, Andrea T.

AU - Spates, C. Richard

AU - McChargue, Dennis E.

AU - Bailey, Katherine C.

AU - Schneider, Kristin L.

AU - Liepman, Michael R.

PY - 2007/1/22

Y1 - 2007/1/22

N2 - In vivo exposure has become the gold standard treatment for specific phobia. The endogenous opioid system is one mechanism proposed to explain why exposure provides such quick and effective treatment for specific phobia. The effect of naltrexone on fear and avoidance behavior was investigated among 15 specific phobia participants who received exposure treatment. Participants were randomly assigned to receive naltrexone, placebo, or no drug prior to attending one-session exposure treatment. Mixed effects regression results revealed that across time, the naltrexone group tolerated significantly less time in the room with the feared animal (Behavioral Avoidance Index) as compared to the placebo and no drug groups. Phobic individuals assigned to the naltrexone group had significantly higher fear ratings across time in comparison to the placebo group. Results provide support for the endogenous opioid system as a potential underlying biological mechanism associated with behavioral changes during in vivo exposure.

AB - In vivo exposure has become the gold standard treatment for specific phobia. The endogenous opioid system is one mechanism proposed to explain why exposure provides such quick and effective treatment for specific phobia. The effect of naltrexone on fear and avoidance behavior was investigated among 15 specific phobia participants who received exposure treatment. Participants were randomly assigned to receive naltrexone, placebo, or no drug prior to attending one-session exposure treatment. Mixed effects regression results revealed that across time, the naltrexone group tolerated significantly less time in the room with the feared animal (Behavioral Avoidance Index) as compared to the placebo and no drug groups. Phobic individuals assigned to the naltrexone group had significantly higher fear ratings across time in comparison to the placebo group. Results provide support for the endogenous opioid system as a potential underlying biological mechanism associated with behavioral changes during in vivo exposure.

KW - Behavioral assessment

KW - Endogenous opiates

KW - Naltrexone

KW - Phobias

UR - http://www.scopus.com/inward/record.url?scp=33846187665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846187665&partnerID=8YFLogxK

U2 - 10.1016/j.janxdis.2006.03.011

DO - 10.1016/j.janxdis.2006.03.011

M3 - Article

C2 - 16647240

AN - SCOPUS:33846187665

VL - 21

SP - 142

EP - 152

JO - Journal of Anxiety Disorders

JF - Journal of Anxiety Disorders

SN - 0887-6185

IS - 1

ER -